Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

IST/ANGEN stock hub

IST/ANGEN has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

IST/ANGENis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.9B

Istanbul Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

IST/ANGEN

In the news

Latest news · IST/ANGEN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-16.6

P25 n/aP50 n/aP75 n/a

ROIC-2.9

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All IST/ANGEN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

179

Groups with data

Currency

TRY

Showing 179 of 179 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Turkey
Country code	TR
Employees	249
Employees Change	26%
Employees Change Percent	11.66
Enterprise value	TRY 3.1B
Exchange	Istanbul Stock Exchange
Financial currency	TRY
First seen	2026-05-10
Industry	Medical Devices
Isin	TREANGN00028
Last refreshed	2026-05-10
Market cap	TRY 2.9B
Price	TRY 13.37
Price currency	TRY
Rev Per Employee	2,970,396.07x
Sector	Healthcare
Sic	2835
Symbol	ist/ANGEN
Website	https://www.anatoliageneworks.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-10.63%
EV Earnings	-10.02x
EV/EBITDA	39.29x
EV/FCF	-16.84x
EV/Sales	4.24x
FCF yield	-6.33%
P/B ratio	1.69x
P/S ratio	3.98x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-7.17%
EBITDA Margin	10.56%
Gross margin	63.55%
Gross Profit	TRY 470M
Gross Profit Growth	7.32%
Gross Profit Growth Q	28.11%
Gross Profit Growth3 Y	5.38%
Net Income	TRY -312.7M
Pretax Margin	-36.82%
Profit Margin	-42.28%
Profit Per Employee	TRY -1.3M
ROA	-1.41
Roa5y	8.57
ROCE	-2.52
ROE	-16.6
Roe5y	6.32
ROIC	-2.9
Roic5y	18.96

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	22.12%
Cagr3y	4.05%
OCF Growth	35%
OCF Growth Q	2,904.76%
OCF Growth3 Y	-25.17%
Revenue Growth	6.65x
Revenue Growth Q	23.12x
Revenue Growth3 Y	16.45x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TRY 0.31
Assets	TRY 2.4B
Cash	TRY 102.7M
Current Assets	TRY 724.4M
Current Liabilities	TRY 256.5M
Debt	TRY 295.8M
Debt EBITDA	TRY 3.71
Debt Equity	TRY 0.17
Debt FCF	TRY -1.59
Equity	TRY 1.7B
Interest Coverage	-22.09
Liabilities	TRY 625.2M
Long Term Assets	TRY 1.6B
Long Term Liabilities	TRY 368.6M
Net Cash	TRY -193.1M
Net Cash By Market Cap	TRY -6.57
Net Debt EBITDA	TRY 2.47
Net Debt Equity	TRY 0.11
Tangible Book Value	TRY 1.7B
Tangible Book Value Per Share	TRY 7.89
WACC	3.99

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.82
Inventory Turnover	0.66
Net Working Capital	TRY 462.1M
Quick ratio	1.25
Working Capital	TRY 467.9M
Working Capital Turnover	TRY 1.1

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend per share	TRY 0
Last Dividend	TRY 0.6

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	22.1%
200-day SMA	11.5
3Y total return	12.64%
50-day SMA	10.72
50-day SMA vs 200-day SMA	50under200
All Time High	25.03
All Time High Change	-46.57%
All Time High Date	2022-12-13
All Time Low	9.23
All Time Low Change	44.85%
All Time Low Date	2023-05-15
ATR	0.4
Beta	0.01
Beta1y	1
Beta2y	0.41
Ch YTD	23.68
High	13.37
High52	14.32
High52 Date	2025-10-06
High52ch	-6.63%
Low	12.5
Low52	9.6
Low52 Date	2025-06-23
Low52ch	39.27%
Ma50ch	24.72%
Price vs 200-day SMA	16.3%
RSI	82.45
RSI Monthly	55.14
RSI Weekly	66.25
Sharpe ratio	0.61x
Sortino ratio	1.11
Tr YTD	23.68
Tr1m	29.18%
Tr1w	19.7%
Tr3m	19.48%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TRY -53M
Operating margin	-7.17

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	40,834,714%
Net Borrowing	89,638,507
Shares Insiders	63.26%
Shares Institutions	0.14%
Shares Out	220,000,000
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TRY -186.1M
Average Volume	2,714,358.7x
Bv Per Share	7.9
CAPEX	TRY -436M
Ch1m	29.18
Ch1w	19.7
Ch1y	22.1
Ch3m	19.48
Ch3y	12.64
Ch6m	12.26
Change	9.95%
Change From Open	6.03
Close	12.16
Days Gap	3.7
Depreciation Amortization	131,123,565
Dollar Volume	144,921,574.7
Earnings Date	2026-05-15
EBIT	TRY -53M
EBITDA	TRY 78.1M
EPS	TRY -1.42
F Score	3
FCF	TRY -186.1M
FCF EV Yield	-5.94x
FCF Per Share	TRY -0.85
Financing CF	74,657,074
Fiscal Year End	December
Founded	2,010
Income Tax	TRY 40.4M
Investing CF	-426,832,175
Is Primary Listing	1
Last Earnings Date	2026-02-27
Last Report Date	2025-12-31
Last Split Date	2023-05-18
Last Split Type	Forward
Ma150	11.27
Ma150ch	18.69%
Ma20	11.27
Ma20ch	18.59%
Net CF	-165,627,799
Next Earnings Date	2026-05-15
Open	12.61
P OCF Ratio	11.77
Position In Range	100
Ppne	975,728,358
Price Date	2026-05-08
Price EBITDA	TRY 37.66
Ptbv Ratio	1.69
Relative Volume	3.99x
Revenue	739,628,622x
Tax By Revenue	5.46x
Tr6m	12.26%
Volume	10,839,310
Z Score	2.71

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does IST/ANGEN pay a dividend?

Capital-return profile for this ticker.

Performance

IST/ANGEN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns IST/ANGEN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.1%

Share of float held by funds and institutions

Insider ownership

+63.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

IST/ANGEN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

82.5

Above 70: short-term overbought

Price vs 200-day MA

+16.3%

50/200-day relationship not available

Beta (5Y)

0.01

Less volatile than the market

Sharpe ratio

0.61

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About IST/ANGEN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ist/ANGEN stock rating?

ist/ANGEN is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ist/ANGEN analysis?

The full report lives at /stocks/ist/ANGEN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ist/ANGEN?

The latest report frames ist/ANGEN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ist/ANGEN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.